Cocoa extract for migraine prevention study
Part of Brain & nervous system clinical trials.
This trial tests whether taking cocoa extract daily can help prevent migraine attacks in people with 4-14 migraines per month. You'll use a phone app to track your headaches and take either cocoa extract or a placebo.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older and have had a doctor diagnose you with migraine (not chronic migraine) for at least 1 year
- You have 4 to 14 migraine attacks per month
- You are not currently taking new migraine medicines or starting new therapies in the past 3 months
- You are willing to use a smartphone app (iPhone or Android) and complete daily headache diaries for 28 days
- You do not have certain serious health conditions like stroke, epilepsy, or bipolar disorder
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how psilocybin affects the brain in people with migraines and in healthy volunteers. The goal is to understand why it may help with headache disorders.
This trial tests whether a combination of vitamins and supplements can help prevent migraines. It's for adults who have migraines often (at least 6 days per month) and want to try a non-drug option.
This study tests new ways to monitor how well preventive migraine treatments are working. It is for people with chronic migraine who may be starting or already using preventive medications.
This study tests whether changing what you eat can help reduce migraine attacks. You would follow a special diet for a period of time while keeping your current migraine medications stable.
This study tests a web-based app designed to help people manage migraines through behavioral and psychosocial methods. The app will track your migraines daily and provide support to potentially reduce their frequency and impact.
This study tests a new inhaled powder form of a migraine medication called dihydroergotamine (DHE) to see if it safely and effectively stops migraine attacks. If you have frequent migraines, this trial might offer you a new treatment option to try.
Hear when a new Migraine trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.